Mutually Isomeric 2- and 4-(3-nitro-1,2,4-triazol-1-yl)pyrimidines Inspired by an Antimycobacterial Screening Hit: Synthesis and Biological Activity against the ESKAPE Panel of Pathogens.

3-nitro-1,2,4-triazole ESKAPE pathogens antimycobacterial activity bioreducible prodrugs cyclic voltammetry nitroazoles nucleophilic aromatic substitution reversible single-electron reduction

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
01 Oct 2020
Historique:
received: 06 09 2020
revised: 24 09 2020
accepted: 30 09 2020
entrez: 6 10 2020
pubmed: 7 10 2020
medline: 7 10 2020
Statut: epublish

Résumé

Starting from the structure of antimycobacterial screening hit OTB-021 which was devoid of activity against ESKAPE pathogens, we designed, synthesized and tested two mutually isomeric series of novel simplified analogs, 2- and 4-(3-nitro-1,2,4-triazol-1-yl)pyrimidines, bearing various amino side chains. These compounds demonstrated a reverse bioactivity profile being inactive against

Identifiants

pubmed: 33019787
pii: antibiotics9100666
doi: 10.3390/antibiotics9100666
pmc: PMC7601023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 14.W03.031.0025

Références

Mutat Res. 1981 Jun;82(1):137-45
pubmed: 6790977
J Med Chem. 2019 Mar 28;62(6):2851-2893
pubmed: 30295477
J Antimicrob Chemother. 1993 Jan;31(1):9-20
pubmed: 8444678
J Gen Microbiol. 1977 Jun;100(2):283-98
pubmed: 330810
Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308
pubmed: 23458769
Chemistry. 2012 Nov 19;18(47):15031-7
pubmed: 23033218
Chem Asian J. 2014 Jan;9(1):166-78
pubmed: 24124178
Eur J Med Chem. 2018 Sep 5;157:1115-1126
pubmed: 30179748
Eur J Med Chem. 2019 Mar 15;166:125-135
pubmed: 30703656
Antimicrob Agents Chemother. 2014 Jul;58(7):3727-36
pubmed: 24752262
Antimicrob Agents Chemother. 2003 Nov;47(11):3616-9
pubmed: 14576129
Eur J Med Chem. 2016 Nov 10;123:895-904
pubmed: 27543881
Pharmaceuticals (Basel). 2018 May 29;11(2):
pubmed: 29844300
Bioorg Med Chem. 2017 Mar 15;25(6):1867-1874
pubmed: 28214232
Nat Protoc. 2008;3(2):163-75
pubmed: 18274517
J Org Chem. 2003 Mar 7;68(5):1867-71
pubmed: 12608803
Am J Clin Pathol. 1966 Apr;45(4):493-6
pubmed: 5325707
Nature. 2000 Jun 22;405(6789):962-6
pubmed: 10879539
Mini Rev Med Chem. 2018;18(20):1733-1752
pubmed: 30173645
PLoS Med. 2006 Nov;3(11):e466
pubmed: 17132069

Auteurs

Sergey Chuprun (S)

Institute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.

Dmitry Dar'in (D)

Institute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.

Elizaveta Rogacheva (E)

Pasteur Institute of Epidemiology and Microbiology, 14 Mira Street, 197101 Saint Petersburg, Russia.

Liudmila Kraeva (L)

Pasteur Institute of Epidemiology and Microbiology, 14 Mira Street, 197101 Saint Petersburg, Russia.

Oleg Levin (O)

Institute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.

Olga Manicheva (O)

Saint Petersburg Research Institute of Phthisiopulmonology, 2-4 Ligovsky Prospekt, 191036 Saint Petersburg, Russia.

Marine Dogonadze (M)

Saint Petersburg Research Institute of Phthisiopulmonology, 2-4 Ligovsky Prospekt, 191036 Saint Petersburg, Russia.

Tatiana Vinogradova (T)

Saint Petersburg Research Institute of Phthisiopulmonology, 2-4 Ligovsky Prospekt, 191036 Saint Petersburg, Russia.

Olga Bakulina (O)

Institute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.

Mikhail Krasavin (M)

Institute of Chemistry, Saint Petersburg State University, 199034 Saint Petersburg, Russia.
Institute of Living Systems, Immanuel Kant Baltic Federal University, 236016 Kaliningrad, Russia.

Classifications MeSH